Bayer · 6 days ago
Sr Director, Global Translational Sciences Lead, Molecular Imaging
Whippany, NJ
Full-time
Hybrid
Director/Executive
$250K/yr - $375K/yr
10+ years expBayer is a visionary company dedicated to solving the world’s toughest challenges in health and hunger. They are seeking a Senior Director, Global Translational Sciences Lead, Molecular Imaging to drive the development of translational and biomarker objectives for preclinical and early clinical strategies, focusing on innovating radiopharmaceuticals for diagnostics and therapeutics.
BiotechnologyChemicalHealth CareLife SciencePharmaceutical
Responsibilities
Ensure effective collaborations between preclinical research and clinical development, establishing strong target-to-disease connections for radiotracers as standalone diagnostics or in co-development with targeted radiotherapies (TRTs) or other therapeutics
Integrate and validate technical knowledge of radiopharmaceuticals’ mechanisms of action and identification of imaging biomarkers in preclinical development into strategies for the clinical development of diagnostic assets
Develop the overall early clinical development strategy of radiotracer assets in co-creation with relevant thought-leader communities, vendors, and partners with a central customer/patient value approach
Develop and oversee clinical trial designs (First in Human to Phase 2a) for radiotracer assets, in collaboration with vendors and partners
Lead the matrix-management of clinical trial teams, collaborating across the organization and externally with service providers/investigator sites
Lead all aspects of translational studies and deliverables with CROs and collaborators to support new and ongoing clinical studies
Provide technical expertise as required for the development, troubleshooting, and tech transfer of manufacturing methods to external vendors/partners
Support the development of cGLP and cGMP radiopharmaceutical manufacturing processes to enable clinical development activities
Review experimental data both internally and from external vendors/partners, analyze, summarize, and interpret results, and relay findings to stakeholders, internal and external (including representing Bayer at regulatory meetings) through summary reports, technical documents, or presentations
Author/co-author pre-clinical and clinical documents as applicable, such as IBs, protocols, study reports, statistical analysis plans, publications, and regulatory submissions
Support optimization of standard methodologies in clinical trial operations and adopt an open learning and sharing environment, optimizing methodologies and utilizing digital tools in clinical trials
May support and contribute to Business Development & Licensing (BD&L) activities
Mentor colleagues and promote knowledge-sharing
Qualification
Required
Minimum of a Master's Degree, MD, PharmD, or PhD in Molecular Imaging/Nuclear Medicine or a related field
At least 10 years of experience in the Pharma Industry, with 5 or more years in Translational Science/Medicine and/or Early Clinical Development (Phase 1-2a) of Radiopharmaceuticals, preferably in diagnostic radiotracers
A track record of clinical trial management/operations of Radiopharmaceuticals and broad knowledge of the drug development field, including experience leading CROs for translational studies and biomarkers for clinical trials
Proven experience with FDA regulatory requirements and ICH GCP guidelines for the development of radiopharmaceuticals, preferably diagnostic radiotracers (IND submission, FDA formal meetings, etc.). Experience with other international health authorities will be valued
Proven understanding/expertise of radiopharmaceutical mechanisms of action, including chemistry, physio- and pathophysiological mechanisms, clinical biomarker development, and pathways of disease and treatment of TRTs and PET/SPECT tracers
Strong VACC (visionary, architect, catalyst, coach) leadership behaviors
Excellent communication and presentation skills (fluent in business English), with clear written and verbal expression of ideas and an active communicator
Preferred
Experience with other international health authorities and their regulatory requirements
Knowledge of TRTs and PET/SPECT tracers in the context of disease pathways and treatment
Benefits
Health care
Vision
Dental
Retirement
PTO
Sick leave
Company
Bayer
Bayer is a life science company that specializes in the areas of health care and agriculture.
10001+ employees
H1B Sponsorship
Bayer has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (62)
2024 (71)
2023 (76)
2022 (141)
2021 (138)
2020 (117)
Funding
Current Stage
Public CompanyTotal Funding
$9.34BKey Investors
Bank of AmericaBill & Melinda Gates FoundationTemasek Holdings
2025-09-26Post Ipo Debt· $331.5M
2024-12-06Post Ipo Debt· $5.29B
2022-11-08Grant· $12M
Leadership Team
Wolfgang Nickl
Member of the Board of Management of Bayer AG and CFO
Abi Abitorabi
VP, CGT Platform Implementation Lead
Recent News
Morningstar.com
2026-01-20
2026-01-20
Company data provided by crunchbase